Hedge Fund - Diamond Hill Capital
Abbott Laboratories (ABT)
Holding History Records
No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
---|---|---|---|---|---|
1 | 2023 - Q4 (2023-12-31) | $573,707,514 | 2.52% | 5,212,206 | $99.92 |
2 | 2023 - Q3 (2023-09-30) | $490,456,148 | 2.37% | 5,064,080 | $105.03 |
3 | 2023 - Q2 (2023-06-30) | $553,416,155 | 2.48% | 5,076,281 | $106.59 |
4 | 2023 - Q1 (2023-03-31) | $528,719,504 | 2.47% | 5,221,405 | $105.58 |
5 | 2022 - Q4 (2022-12-31) | $583,545,209 | 2.65% | 5,315,103 | $103.54 |
6 | 2022 - Q3 (2022-09-30) | $554,454,000 | 2.65% | 5,730,200 | $106.59 |
7 | 2022 - Q2 (2022-06-30) | $639,592,000 | 2.79% | 5,886,717 | $113.57 |
8 | 2022 - Q1 (2022-03-31) | $721,992,000 | 2.68% | 6,099,963 | $123.97 |
9 | 2021 - Q4 (2021-12-31) | $851,455,000 | 3.04% | 6,049,845 | $128.00 |
10 | 2021 - Q3 (2021-09-30) | $732,623,000 | 2.77% | 6,201,838 | $122.84 |
11 | 2021 - Q2 (2021-06-30) | $722,696,000 | 2.74% | 6,233,901 | $116.58 |
12 | 2021 - Q1 (2021-03-31) | $726,745,000 | 2.93% | 6,064,293 | $118.48 |
13 | 2020 - Q4 (2020-12-31) | $644,687,000 | 3.03% | 5,888,095 | $108.70 |
14 | 2020 - Q3 (2020-09-30) | $609,764,000 | 3.36% | 5,602,900 | $101.45 |
15 | 2020 - Q2 (2020-06-30) | $579,244,000 | 3.41% | 6,335,377 | $90.38 |
16 | 2020 - Q1 (2020-03-31) | $498,269,000 | 3.37% | 6,314,402 | $83.44 |
17 | 2019 - Q4 (2019-12-31) | $554,442,000 | 2.78% | 6,383,171 | $83.75 |
18 | 2019 - Q3 (2019-09-30) | $536,506,000 | 2.85% | 6,412,163 | $84.97 |
19 | 2019 - Q2 (2019-06-30) | $547,779,000 | 2.92% | 6,513,423 | $78.72 |
20 | 2019 - Q1 (2019-03-31) | $557,587,000 | 3.06% | 6,975,064 | $74.40 |
21 | 2018 - Q4 (2018-12-31) | $551,527,000 | 3.23% | 7,625,148 | $70.28 |
22 | 2018 - Q3 (2018-09-30) | $653,352,000 | 3.25% | 8,906,108 | $65.66 |
23 | 2018 - Q2 (2018-06-30) | $617,031,000 | 3.16% | 10,116,925 | $60.63 |
24 | 2018 - Q1 (2018-03-31) | $627,164,000 | 3.21% | 10,466,682 | $60.25 |
25 | 2017 - Q4 (2017-12-31) | $602,644,000 | 3.01% | 10,559,736 | $55.42 |
26 | 2017 - Q3 (2017-09-30) | $589,082,000 | 3.1% | 11,039,767 | $50.17 |
27 | 2017 - Q2 (2017-06-30) | $581,574,000 | 3.13% | 11,964,081 | $45.27 |
28 | 2017 - Q1 (2017-03-31) | $545,861,000 | 3.05% | 12,291,387 | $43.23 |
29 | 2016 - Q4 (2016-12-31) | $479,664,000 | 2.78% | 12,488,011 | $39.65 |
30 | 2016 - Q3 (2016-09-30) | $502,227,000 | 3.1% | 11,875,781 | $42.85 |
31 | 2016 - Q2 (2016-06-30) | $470,488,000 | 2.97% | 11,968,670 | $39.80 |
32 | 2016 - Q1 (2016-03-31) | $426,586,000 | 2.71% | 10,198,087 | $39.62 |
33 | 2015 - Q4 (2015-12-31) | $387,203,000 | 2.57% | 8,621,765 | $44.15 |
34 | 2015 - Q3 (2015-09-30) | $337,261,000 | 2.33% | 8,385,413 | $47.14 |
35 | 2015 - Q2 (2015-06-30) | $395,717,000 | 2.62% | 8,062,685 | $48.02 |
36 | 2015 - Q1 (2015-03-31) | $375,592,000 | 2.6% | 8,106,888 | $45.92 |
37 | 2014 - Q4 (2014-12-31) | $363,344,000 | 2.59% | 8,070,717 | $43.56 |
38 | 2014 - Q3 (2014-09-30) | $317,098,000 | 2.44% | 7,624,383 | $42.30 |
39 | 2014 - Q2 (2014-06-30) | $262,671,000 | 2.06% | 6,422,284 | $39.27 |
40 | 2014 - Q1 (2014-03-31) | $230,471,000 | 1.97% | 5,984,714 | $38.55 |
41 | 2013 - Q4 (2013-12-31) | $118,378,000 | 1.07% | 3,088,381 | $36.86 |
42 | 2013 - Q3 (2013-09-30) | $102,298,000 | 1.03% | 3,082,184 | $35.09 |
43 | 2012 - Q3 (2012-09-30) | $247,812,000 | 2.8% | 7,533,411.8,382,659 | $31.87 |
44 | 2012 - Q1 (2012-03-31) | $226,778,000 | 2.64% | 7,711,727.8,032,514 | $27.30 |
45 | 2011 - Q4 (2011-12-31) | $211,385,000 | 2.64% | 7,835,125.052,105 | $25.75 |
46 | 2011 - Q3 (2011-09-30) | $189,292,000 | 2.68% | 7,714,553.9,808,253 | $24.59 |
47 | 2011 - Q2 (2011-06-30) | $222,345,000 | 2.65% | 8,806,759.0,662,776 | $24.91 |
48 | 2011 - Q1 (2011-03-31) | $208,972,000 | 2.48% | 8,879,518.5,493,956 | $22.72 |
49 | 2010 - Q4 (2010-12-31) | $190,273,000 | 2.4% | 8,277,334.3,059,608 | $23.82 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
10000.0000:4798.0000 on 2013-01-02